152 related articles for article (PubMed ID: 38218782)
21. Comparison of patient flow and provider efficiency of two delivery strategies for HPV-based cervical cancer screening in Western Kenya: a time and motion study.
Olwanda E; Shen J; Kahn JG; Bryant-Comstock K; Huchko MJ
Glob Health Action; 2018; 11(1):1451455. PubMed ID: 29589991
[TBL] [Abstract][Full Text] [Related]
22. A Qualitative Exploration of Barriers to Treatment Among HPV-Positive Women in a Cervical Cancer Screening Study in Western Kenya.
Isaacson S; Adewumi K; Smith JS; Novak C; Oketch S; Huchko MJ
Oncologist; 2023 Jan; 28(1):e9-e18. PubMed ID: 36239434
[TBL] [Abstract][Full Text] [Related]
23. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
24. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
25. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
[TBL] [Abstract][Full Text] [Related]
26. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
[TBL] [Abstract][Full Text] [Related]
27. Effects of Message Framing on Cervical Cancer Screening Knowledge and Intentions Related to Primary HPV Testing.
Ogden SN; Leskinen EA; Sarma EA; Wainwright JV; Rendle KA
Cancer Prev Res (Phila); 2021 Sep; 14(9):839-844. PubMed ID: 33846214
[TBL] [Abstract][Full Text] [Related]
28. Stepwise strategy to improve cervical cancer screening adherence (SCAN-Cervical Cancer) - Automated text messages, phone calls and reminders: Population based randomized controlled trial.
Firmino-Machado J; Varela S; Mendes R; Moreira A; Lunet N;
Prev Med; 2018 Sep; 114():123-133. PubMed ID: 29894717
[TBL] [Abstract][Full Text] [Related]
29. A Qualitative Exploration of Women's Experiences with a Community Health Volunteer-Led Cervical Cancer Educational Module in Migori County, Kenya.
Choi Y; Oketch SY; Adewumi K; Bukusi E; Huchko MJ
J Cancer Educ; 2020 Feb; 35(1):36-43. PubMed ID: 30368651
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the costs of HPV testing through community health campaigns versus home-based testing in rural Western Kenya: a microcosting study.
Olwanda EE; Kahn JG; Choi Y; Islam JY; Huchko M
BMJ Open; 2020 Oct; 10(10):e033979. PubMed ID: 33109637
[TBL] [Abstract][Full Text] [Related]
31. Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
Mwenda V; Bor JP; Nyangasi M; Njeru J; Olwande S; Njiri P; Arbyn M; Weyers S; Tummers P; Temmerman M
PLoS One; 2023; 18(5):e0286202. PubMed ID: 37228154
[TBL] [Abstract][Full Text] [Related]
32. Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya.
Shin MB; Oluoch LM; Barnabas RV; Baynes C; Fridah H; Heitner J; Kerubo MB; Ngure K; Pinder LF; Thomas KK; Mugo NR; Gimbel S
Implement Sci; 2023 Jun; 18(1):26. PubMed ID: 37365575
[TBL] [Abstract][Full Text] [Related]
33. Systems-level barriers to treatment in a cervical cancer prevention program in Kenya: Several observational studies.
Page CM; Ibrahim S; Park LP; Huchko MJ
PLoS One; 2020; 15(7):e0235264. PubMed ID: 32658921
[TBL] [Abstract][Full Text] [Related]
34. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
[TBL] [Abstract][Full Text] [Related]
35. Female perspectives on male involvement in a human-papillomavirus-based cervical cancer-screening program in western Kenya.
Adewumi K; Oketch SY; Choi Y; Huchko MJ
BMC Womens Health; 2019 Aug; 19(1):107. PubMed ID: 31395060
[TBL] [Abstract][Full Text] [Related]
36. Stepwise strategy to improve Cervical Cancer Screening Adherence (SCAN-CC): automated text messages, phone calls and face-to-face interviews: protocol of a population-based randomised controlled trial.
Firmino-Machado J; Mendes R; Moreira A; Lunet N
BMJ Open; 2017 Oct; 7(10):e017730. PubMed ID: 28982833
[TBL] [Abstract][Full Text] [Related]
37. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
38. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
[TBL] [Abstract][Full Text] [Related]
39. Development of a cervical cancer prevention text-messaging program for women living with HIV.
Ciceron AC; Berg CJ; Clausen M; Jeon MJ; Abroms LC; Le D
Health Educ Res; 2023 Dec; 38(6):587-596. PubMed ID: 37436827
[TBL] [Abstract][Full Text] [Related]
40. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
